PR001265 (Project)

Description:Here, we analyzed BAs in a longitudinal series of serum (n= 333) collected at 3, 6, 12, 18, 24 and 36 months of age, from children who developed a single islet autoantibody (P1Ab), multiple islet autoantibodies (P2Ab), and controls (CTRs) who remained autoantibody (AAb) negative during the follow-up.
Results found

Linked to

 

Label

Description

 

Project

Metabolomics

Subject

A subject from Metabolomics produced as part of the PR001265 project

Subject

A subject from Metabolomics produced as part of the PR001265 project

Biosample

A biosample from Metabolomics produced as part of the PR001265 project

Biosample

A biosample from Metabolomics produced as part of the PR001265 project

Biosample

A biosample from Metabolomics produced as part of the PR001265 project

Biosample

A biosample from Metabolomics produced as part of the PR001265 project

Biosample

A biosample from Metabolomics produced as part of the PR001265 project

Biosample

A biosample from Metabolomics produced as part of the PR001265 project

Biosample

A biosample from Metabolomics produced as part of the PR001265 project


  • Subject

    A subject from Metabolomics produced as part of the PR001265 project


  • Subject

    A subject from Metabolomics produced as part of the PR001265 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR001265 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR001265 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR001265 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR001265 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR001265 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR001265 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR001265 project

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.